Free Trial

Enanta Pharmaceuticals (ENTA) Stock Chart & Stock Price History

Enanta Pharmaceuticals logo
$12.50 +0.40 (+3.31%)
Closing price 10/9/2026 04:00 PM Eastern
Extended Trading
$12.56 +0.06 (+0.50%)
As of 10/9/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Enanta Pharmaceuticals Stock Price Performance

The Enanta Pharmaceuticals (ENTA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 13.43%, with a year-to-date return of -20.74%. In the past month, the stock has decreased 1.57%, reflecting recent market activity.

As of the latest close, Enanta Pharmaceuticals traded at $12.50 with a market cap of $364 million and volume of 182,070 shares. Five years ago, the stock traded at $70.10, representing a 82.17% decrease over that period. At the time, it had a market cap of $1.42 billion and a volume of 198,379 shares.

Receive ENTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.79%
1 Month
Performance
-1.57%
3 Month
Performance
-8.76%
Year-To-Date
Performance
-20.74%
1 Year
Performance
+13.43%
5 Year
Performance
-82.17%

ENTA Stock Chart for Saturday, October, 10, 2026

Enanta Pharmaceuticals Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/09/2026$12.10$12.50
+3.31%
$12.61$12.07182,070 shs$364 million
10/08/2026$12.37$12.10
-2.18%
$12.35$11.70282,900 shs$352.35 million
10/07/2026$12.17$12.37
+1.64%
$12.57$12.05191,664 shs$360.28 million
10/06/2026$12.60$12.17
-3.41%
$12.66$11.97271,692 shs$354.39 million
10/05/2026$12.96$12.60
-2.78%
$13.03$12.47218,871 shs$366.91 million
10/02/2026$12.84$12.96
+0.93%
$13.21$12.58748,002 shs$377.40 million
10/01/2026$13.20$12.84
-2.69%
$13.45$12.83331,486 shs$373.97 million
09/30/2026$12.64$13.20
+4.39%
$13.41$12.44425,883 shs$384.24 million
09/29/2026$12.61$12.64
+0.24%
$12.85$12.43322,819 shs$368.08 million
09/28/2026$11.88$12.61
+6.14%
$12.68$11.69349,326 shs$367.27 million
09/25/2026$12.00$11.88
-1.00%
$12.00$11.64217,316 shs$346.01 million
09/24/2026$11.95$12.00
+0.42%
$12.02$11.67206,239 shs$349.44 million
09/23/2026$12.42$11.95
-3.78%
$12.33$11.87206,320 shs$347.98 million
09/22/2026$12.11$12.42
+2.56%
$12.47$12.03164,644 shs$361.73 million
09/21/2026$12.20$12.11
-0.74%
$12.28$11.94217,212 shs$352.64 million
09/18/2026$12.52$12.20
-2.56%
$12.61$12.19428,244 shs$355.26 million
09/17/2026$12.70$12.52
-1.42%
$12.84$12.49277,679 shs$364.58 million
09/16/2026$12.29$12.70
+3.34%
$12.92$12.33267,528 shs$369.89 million
09/15/2026$13.12$12.29
-6.33%
$13.07$12.16284,878 shs$357.89 million
09/14/2026$12.96$13.12
+1.23%
$13.13$12.79280,239 shs$382.05 million
09/11/2026$12.70$12.96
+2.05%
$13.04$12.59289,136 shs$377.40 million
09/10/2026$13.24$12.70
-4.08%
$13.21$12.44312,790 shs$369.89 million

This page (NASDAQ:ENTA) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners